{"hands_on_practices": [{"introduction": "Accurate medication dosing is a cornerstone of pediatric practice, balancing therapeutic efficacy with patient safety. This exercise provides foundational practice in weight-based dose calculation, a daily task for clinicians treating common infections. By working through the standard oral antibiotic regimens for early localized Lyme disease, you will reinforce the principles of linear dose scaling and adherence to established therapeutic guidelines. [@problem_id:5167646]", "problem": "A child weighing $17$ kilograms presents with early localized Lyme disease manifesting as erythema migrans (EM). For EM in pediatrics, standard oral regimens include amoxicillin and doxycycline. The foundational facts to use are:\n- Weight-based dosing is specified in $\\mathrm{mg/kg/day}$ and scales linearly with body weight $W$; total daily dose equals the product of the weight-based dose and $W$, and per-dose amounts are the daily total divided by the number of doses per day.\n- For amoxicillin: the recommended regimen is $50\\,\\mathrm{mg/kg/day}$ divided every $8$ hours (three doses per day), with a maximum of $500\\,\\mathrm{mg}$ per dose, and a conventional duration of therapy of $14$ days for erythema migrans.\n- For doxycycline: the recommended regimen is $4.4\\,\\mathrm{mg/kg/day}$ divided every $12$ hours (two doses per day), with a maximum of $100\\,\\mathrm{mg}$ per dose, and a conventional duration of therapy of $10$ days for erythema migrans. Short courses of doxycycline are acceptable in children of all ages for Lyme disease.\n\nUsing these facts and the principles of linear weight-based scaling, compute for each drug:\n1. The total daily dose in milligrams.\n2. The per-dose amount in milligrams applying the per-dose maximum constraints if needed.\n3. The duration of therapy in days.\n\nExpress all doses in milligrams and all durations in days. Round all dose quantities to three significant figures. Provide your final results in the order: amoxicillin total daily dose, amoxicillin per-dose, amoxicillin duration, doxycycline total daily dose, doxycycline per-dose, doxycycline duration.", "solution": "The problem statement is validated as scientifically grounded, well-posed, objective, and self-contained. All provided data and definitions are consistent with established pediatric clinical guidelines for the treatment of Lyme disease. The problem is a formalizable set of calculations based on clear principles. Therefore, a solution will be derived.\n\nThe problem requires the calculation of three quantities for two drugs, amoxicillin and doxycycline: the total daily dose, the per-dose amount, and the duration of therapy. The calculations will be performed for each drug sequentially, adhering to the given parameters and constraints.\n\nLet $W$ be the child's weight, given as $W = 17\\,\\mathrm{kg}$.\n\nFirst, we analyze the regimen for amoxicillin.\nThe given parameters for amoxicillin are:\n- Weight-based dose rate, $d_A = 50\\,\\mathrm{mg/kg/day}$.\n- Number of doses per day, $n_A = 3$ (corresponding to administration every $8$ hours).\n- Maximum per-dose amount, $P_{A, \\text{max}} = 500\\,\\mathrm{mg}$.\n- Duration of therapy, $T_A = 14\\,\\mathrm{days}$.\n\n1.  **Amoxicillin: Total Daily Dose**\n    The total daily dose, $D_{A, \\text{daily}}$, is calculated by multiplying the weight-based dose rate by the child's weight:\n    $$D_{A, \\text{daily}} = d_A \\times W$$\n    Substituting the given values:\n    $$D_{A, \\text{daily}} = 50\\,\\mathrm{mg/kg/day} \\times 17\\,\\mathrm{kg} = 850\\,\\mathrm{mg/day}$$\n    The problem specifies rounding dose quantities to three significant figures. The calculated value is $850\\,\\mathrm{mg/day}$.\n\n2.  **Amoxicillin: Per-Dose Amount**\n    The calculated per-dose amount, $P_{A, \\text{calc}}$, is the total daily dose divided by the number of doses per day:\n    $$P_{A, \\text{calc}} = \\frac{D_{A, \\text{daily}}}{n_A}$$\n    $$P_{A, \\text{calc}} = \\frac{850\\,\\mathrm{mg}}{3} \\approx 283.333...\\,\\mathrm{mg}$$\n    This calculated amount must be compared to the maximum allowed per-dose amount, $P_{A, \\text{max}} = 500\\,\\mathrm{mg}$. The effective per-dose amount, $P_A$, is the minimum of the calculated and maximum values:\n    $$P_A = \\min(P_{A, \\text{calc}}, P_{A, \\text{max}})$$\n    Since $283.333...\\,\\mathrm{mg}  500\\,\\mathrm{mg}$, the constraint is not exceeded.\n    $$P_A \\approx 283.333...\\,\\mathrm{mg}$$\n    Rounding this dose quantity to three significant figures gives:\n    $$P_A = 283\\,\\mathrm{mg}$$\n\n3.  **Amoxicillin: Duration of Therapy**\n    The duration of therapy for amoxicillin is given directly in the problem statement:\n    $$T_A = 14\\,\\mathrm{days}$$\n\nNext, we analyze the regimen for doxycycline.\nThe given parameters for doxycycline are:\n- Weight-based dose rate, $d_D = 4.4\\,\\mathrm{mg/kg/day}$.\n- Number of doses per day, $n_D = 2$ (corresponding to administration every $12$ hours).\n- Maximum per-dose amount, $P_{D, \\text{max}} = 100\\,\\mathrm{mg}$.\n- Duration of therapy, $T_D = 10\\,\\mathrm{days}$.\n\n1.  **Doxycycline: Total Daily Dose**\n    The total daily dose, $D_{D, \\text{daily}}$, is calculated as:\n    $$D_{D, \\text{daily}} = d_D \\times W$$\n    Substituting the given values:\n    $$D_{D, \\text{daily}} = 4.4\\,\\mathrm{mg/kg/day} \\times 17\\,\\mathrm{kg} = 74.8\\,\\mathrm{mg/day}$$\n    This value already has three significant figures, so no additional rounding is needed.\n\n2.  **Doxycycline: Per-Dose Amount**\n    The calculated per-dose amount, $P_{D, \\text{calc}}$, is:\n    $$P_{D, \\text{calc}} = \\frac{D_{D, \\text{daily}}}{n_D}$$\n    $$P_{D, \\text{calc}} = \\frac{74.8\\,\\mathrm{mg}}{2} = 37.4\\,\\mathrm{mg}$$\n    This calculated amount is compared to the maximum allowed per-dose amount, $P_{D, \\text{max}} = 100\\,\\mathrm{mg}$.\n    $$P_D = \\min(P_{D, \\text{calc}}, P_{D, \\text{max}})$$\n    Since $37.4\\,\\mathrm{mg}  100\\,\\mathrm{mg}$, the constraint is not exceeded. The value is $37.4\\,\\mathrm{mg}$. This value has three significant figures, so no rounding is needed.\n    $$P_D = 37.4\\,\\mathrm{mg}$$\n\n3.  **Doxycycline: Duration of Therapy**\n    The duration of therapy for doxycycline is given directly:\n    $$T_D = 10\\,\\mathrm{days}$$\n\nIn summary, the calculated results are:\n- Amoxicillin total daily dose: $850\\,\\mathrm{mg}$\n- Amoxicillin per-dose: $283\\,\\mathrm{mg}$\n- Amoxicillin duration: $14\\,\\mathrm{days}$\n- Doxycycline total daily dose: $74.8\\,\\mathrm{mg}$\n- Doxycycline per-dose: $37.4\\,\\mathrm{mg}$\n- Doxycycline duration: $10\\,\\mathrm{days}$\n\nThese results will be presented in the specified order in the final answer.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n850  283  14  74.8  37.4  10\n\\end{pmatrix}\n}\n$$", "id": "5167646"}, {"introduction": "Building on fundamental dosing skills, this problem addresses a more complex clinical scenario involving disseminated Lyme disease. It introduces the critical real-world constraint of maximum dose caps, which prevent potential toxicity in heavier pediatric patients where simple weight-based calculations might exceed adult dosages. This practice hones your ability to select and correctly dose both parenteral and oral therapies for severe Lyme manifestations, ensuring safe and effective treatment. [@problem_id:5167617]", "problem": "A $12$-year-old child weighing $55\\,\\mathrm{kg}$ is diagnosed with Lyme meningitis, confirmed by cerebrospinal fluid analysis and serology. According to Infectious Diseases Society of America (IDSA) guidelines for pediatric Lyme neuroborreliosis, acceptable regimens include parenteral ceftriaxone or oral doxycycline for a duration chosen by the institution within the guideline range. The institution uses a fixed $14$-day course for Lyme meningitis and adheres to the following well-tested dosing rules based on body weight and established maximum dose caps:\n\n- Parenteral ceftriaxone daily dose: $75\\,\\mathrm{mg/kg/day}$ once daily, capped at a maximum of $2{,}000\\,\\mathrm{mg/day}$.\n- Oral doxycycline total daily dose: $4.4\\,\\mathrm{mg/kg/day}$ divided every $12$ hours, with a per-dose cap of $100\\,\\mathrm{mg}$ (that is, no single dose may exceed $100\\,\\mathrm{mg}$).\n\nUsing only these dosing principles and the stated $14$-day duration, derive from first principles the total cumulative milligrams that would be administered over the full course for each regimen, accounting for the relevant maximum dose caps. Then compute the numerical difference between the total ceftriaxone milligrams and the total doxycycline milligrams over the $14$ days.\n\nExpress the final difference in milligrams and round your answer to four significant figures. Use $\\mathrm{mg}$ as the unit in your reasoning; do not include units in your final boxed answer.", "solution": "The problem is evaluated to be valid as it is scientifically grounded, well-posed, objective, and contains all necessary information for a unique solution. The scenario presented is a standard pharmacological calculation based on established pediatric guidelines for Lyme disease.\n\nThe objective is to calculate the difference between the total cumulative mass of ceftriaxone and doxycycline administered over a $14$-day course.\n\nLet $W$ be the weight of the child, given as $W = 55\\,\\mathrm{kg}$.\nLet $T$ be the duration of the treatment, given as $T = 14\\,\\mathrm{days}$.\n\nFirst, we will calculate the total cumulative dose for the ceftriaxone regimen. Let this total mass be $M_C$.\nThe prescribed daily dosing rate for ceftriaxone is $R_C = 75\\,\\mathrm{mg/kg/day}$.\nThe calculated ideal daily dose, $D_{C, \\text{ideal}}$, is the product of the child's weight and the dosing rate:\n$$ D_{C, \\text{ideal}} = W \\times R_C = 55\\,\\mathrm{kg} \\times 75\\,\\frac{\\mathrm{mg}}{\\mathrm{kg}\\cdot\\mathrm{day}} = 4125\\,\\frac{\\mathrm{mg}}{\\mathrm{day}} $$\nThe problem states a maximum daily dose cap for ceftriaxone, $D_{C, \\text{max}} = 2000\\,\\mathrm{mg/day}$.\nWe must compare the ideal dose to this cap. Since $D_{C, \\text{ideal}}  D_{C, \\text{max}}$ (i.e., $4125\\,\\mathrm{mg}  2000\\,\\mathrm{mg}$), the actual administered daily dose, $D_{C, \\text{actual}}$, must be the maximum allowed dose.\n$$ D_{C, \\text{actual}} = \\min(D_{C, \\text{ideal}}, D_{C, \\text{max}}) = 2000\\,\\frac{\\mathrm{mg}}{\\mathrm{day}} $$\nThe total cumulative mass of ceftriaxone administered over the $14$-day course is:\n$$ M_C = D_{C, \\text{actual}} \\times T = 2000\\,\\frac{\\mathrm{mg}}{\\mathrm{day}} \\times 14\\,\\mathrm{days} = 28000\\,\\mathrm{mg} $$\n\nNext, we will calculate the total cumulative dose for the doxycycline regimen. Let this total mass be $M_D$.\nThe prescribed total daily dosing rate for doxycycline is $R_D = 4.4\\,\\mathrm{mg/kg/day}$.\nThe calculated ideal total daily dose, $D_{D, \\text{daily, ideal}}$, is:\n$$ D_{D, \\text{daily, ideal}} = W \\times R_D = 55\\,\\mathrm{kg} \\times 4.4\\,\\frac{\\mathrm{mg}}{\\mathrm{kg}\\cdot\\mathrm{day}} = 242\\,\\frac{\\mathrm{mg}}{\\mathrm{day}} $$\nThis total daily dose is divided into two equal single doses, as it is administered every $12$ hours. The ideal single dose, $D_{D, \\text{single, ideal}}$, is therefore:\n$$ D_{D, \\text{single, ideal}} = \\frac{D_{D, \\text{daily, ideal}}}{2} = \\frac{242\\,\\mathrm{mg}}{2} = 121\\,\\mathrm{mg} $$\nThe problem states a maximum per-dose cap for doxycycline, $D_{D, \\text{single, max}} = 100\\,\\mathrm{mg}$.\nWe must compare the ideal single dose to this cap. Since $D_{D, \\text{single, ideal}}  D_{D, \\text{single, max}}$ (i.e., $121\\,\\mathrm{mg}  100\\,\\mathrm{mg}$), the actual administered single dose, $D_{D, \\text{single, actual}}$, must be the maximum allowed dose.\n$$ D_{D, \\text{single, actual}} = \\min(D_{D, \\text{single, ideal}}, D_{D, \\text{single, max}}) = 100\\,\\mathrm{mg} $$\nThe actual total daily dose, $D_{D, \\text{daily, actual}}$, is twice the actual single dose:\n$$ D_{D, \\text{daily, actual}} = 2 \\times D_{D, \\text{single, actual}} = 2 \\times 100\\,\\mathrm{mg} = 200\\,\\frac{\\mathrm{mg}}{\\mathrm{day}} $$\nThe total cumulative mass of doxycycline administered over the $14$-day course is:\n$$ M_D = D_{D, \\text{daily, actual}} \\times T = 200\\,\\frac{\\mathrm{mg}}{\\mathrm{day}} \\times 14\\,\\mathrm{days} = 2800\\,\\mathrm{mg} $$\n\nFinally, we compute the numerical difference, $\\Delta M$, between the total cumulative ceftriaxone and doxycycline masses.\n$$ \\Delta M = M_C - M_D = 28000\\,\\mathrm{mg} - 2800\\,\\mathrm{mg} = 25200\\,\\mathrm{mg} $$\nThe problem requires the answer to be rounded to four significant figures. The calculated difference is $25200$. To express this value with four significant figures, we represent it in scientific notation as $2.520 \\times 10^4$. The numerical value is $25200$.", "answer": "$$\\boxed{2.520 \\times 10^4}$$", "id": "5167617"}, {"introduction": "Effective treatment begins with an accurate diagnosis, yet the interpretation of diagnostic tests is fraught with statistical nuance. This exercise moves from therapeutics to diagnostics, exploring how a test's performance is context-dependent. Using Bayes' theorem, you will derive and apply the concept of positive predictive value ($\\mathrm{PPV}$), demonstrating how a low pretest probability can dramatically reduce confidence in a positive result, even with a sensitive and specific assay. [@problem_id:5167611]", "problem": "A pediatric infectious diseases service wants to formalize how pretest probability influences the interpretation of a positive first-tier Lyme antibody test in children. Consider a $9$-year-old with nonspecific fatigue in late summer, no erythema migrans, and no known tick attachment longer than $36$ hours, living in a region with low pediatric Lyme incidence. The clinician orders a first-tier enzyme immunoassay (EIA) for Borrelia burgdorferi antibodies. Assume the EIA has sensitivity $\\mathrm{Se}=0.90$ and specificity $\\mathrm{Sp}=0.95$ for the pediatric population being tested. The clinician estimates the child’s pretest probability $\\pi$ of true Lyme disease to be $\\pi=0.01$ based on epidemiology and clinical presentation.\n\nStarting from the foundational form of Bayes’ theorem, namely that for events $A$ and $B$ with $P(B)0$, $P(A\\mid B)=\\dfrac{P(B\\mid A)P(A)}{P(B)}$, and using only core test characteristic definitions (sensitivity as $P(+\\mid D)$ and specificity as $P(-\\mid \\overline{D})$), do the following:\n\n1. Derive from first principles an expression for the positive predictive value $\\mathrm{PPV}(\\pi)=P(D\\mid +)$ in terms of $\\mathrm{Se}$, $\\mathrm{Sp}$, and $\\pi$, and then determine analytically whether $\\mathrm{PPV}(\\pi)$ increases or decreases as $\\pi$ increases.\n2. Apply your derived expression to compute the numerical value of $\\mathrm{PPV}$ for the child described above using $\\mathrm{Se}=0.90$, $\\mathrm{Sp}=0.95$, and $\\pi=0.01$.\n\nReport the final numerical answer to part $2$ as a unitless decimal rounded to four significant figures.", "solution": "The problem is valid as it is scientifically grounded in epidemiology and biostatistics, well-posed with sufficient information for a unique solution, and stated objectively. The provided values for sensitivity, specificity, and pretest probability are realistic for the described clinical scenario. The task requires a standard, but rigorous, application of Bayes' theorem.\n\nLet $D$ be the event that the child has true Lyme disease, and let $\\overline{D}$ be the event that the child does not have Lyme disease. Let $+$ be the event that the first-tier EIA test result is positive. We are asked to find the positive predictive value ($\\mathrm{PPV}$), which is the probability of having the disease given a positive test result, denoted as $P(D\\mid +)$.\n\nThe information provided can be expressed in probabilistic terms:\n- The pretest probability of Lyme disease is $P(D) = \\pi = 0.01$.\n- The probability of not having Lyme disease is $P(\\overline{D}) = 1 - P(D) = 1 - \\pi$.\n- The sensitivity of the test is $\\mathrm{Se} = P(+\\mid D) = 0.90$. This is the probability of a positive test given that the child has the disease.\n- The specificity of the test is $\\mathrm{Sp} = P(-\\mid \\overline{D}) = 0.95$, where $-$ denotes a negative test result. This is the probability of a negative test given that the child does not have the disease.\n\n### Part 1: Derivation and Analysis of $\\mathrm{PPV}(\\pi)$\n\nThe derivation begins with the foundational form of Bayes' theorem provided in the problem statement, $P(A\\mid B)=\\dfrac{P(B\\mid A)P(A)}{P(B)}$. We set $A=D$ and $B=+$, yielding:\n$$\n\\mathrm{PPV}(\\pi) = P(D\\mid +) = \\frac{P(+\\mid D)P(D)}{P(+)}\n$$\nThe numerator can be immediately expressed in terms of the given quantities: $P(+\\mid D)P(D) = (\\mathrm{Se})(\\pi)$.\n\nThe denominator, $P(+)$, is the overall probability of a positive test result. This can be calculated using the law of total probability, conditioning on the disease status:\n$$\nP(+) = P(+\\mid D)P(D) + P(+\\mid \\overline{D})P(\\overline{D})\n$$\nWe know $P(+\\mid D) = \\mathrm{Se}$, $P(D) = \\pi$, and $P(\\overline{D}) = 1 - \\pi$. The term $P(+\\mid \\overline{D})$ is the probability of a positive test in a person without the disease (a false positive). This is related to the specificity, $\\mathrm{Sp}$. For any individual without the disease, the test can be either positive or negative, so $P(+\\mid \\overline{D}) + P(-\\mid \\overline{D}) = 1$. The specificity is defined as $\\mathrm{Sp} = P(-\\mid \\overline{D})$, so we have:\n$$\nP(+\\mid \\overline{D}) = 1 - P(-\\mid \\overline{D}) = 1 - \\mathrm{Sp}\n$$\nSubstituting these terms back into the expression for $P(+)$:\n$$\nP(+) = (\\mathrm{Se})(\\pi) + (1 - \\mathrm{Sp})(1 - \\pi)\n$$\nNow, we substitute the expressions for the numerator and the denominator back into Bayes' theorem to obtain the final form of $\\mathrm{PPV}(\\pi)$:\n$$\n\\mathrm{PPV}(\\pi) = \\frac{(\\mathrm{Se})(\\pi)}{(\\mathrm{Se})(\\pi) + (1 - \\mathrm{Sp})(1 - \\pi)}\n$$\nThis completes the derivation of $\\mathrm{PPV}$ in terms of $\\mathrm{Se}$, $\\mathrm{Sp}$, and $\\pi$.\n\nTo determine analytically whether $\\mathrm{PPV}(\\pi)$ increases or decreases as $\\pi$ increases, we compute the derivative of $\\mathrm{PPV}(\\pi)$ with respect to $\\pi$. Let's rewrite the function for clarity:\n$$\n\\mathrm{PPV}(\\pi) = \\frac{(\\mathrm{Se})\\pi}{(\\mathrm{Se} - (1 - \\mathrm{Sp}))\\pi + (1 - \\mathrm{Sp})} = \\frac{(\\mathrm{Se})\\pi}{(\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi + 1 - \\mathrm{Sp}}\n$$\nUsing the quotient rule for differentiation, $\\frac{d}{dx}\\left(\\frac{u}{v}\\right) = \\frac{u'v - uv'}{v^2}$, with $u = (\\mathrm{Se})\\pi$ and $v = (\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi + 1 - \\mathrm{Sp}$:\n$$\n\\frac{d}{d\\pi} \\mathrm{PPV}(\\pi) = \\frac{(\\mathrm{Se}) \\cdot [(\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi + 1 - \\mathrm{Sp}] - [(\\mathrm{Se})\\pi] \\cdot (\\mathrm{Se} + \\mathrm{Sp} - 1)}{[(\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi + 1 - \\mathrm{Sp}]^2}\n$$\nExpanding the numerator:\n$$\n(\\mathrm{Se})(\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi + (\\mathrm{Se})(1 - \\mathrm{Sp}) - (\\mathrm{Se})(\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi = (\\mathrm{Se})(1 - \\mathrm{Sp})\n$$\nSo, the derivative is:\n$$\n\\frac{d}{d\\pi} \\mathrm{PPV}(\\pi) = \\frac{(\\mathrm{Se})(1 - \\mathrm{Sp})}{[(\\mathrm{Se} + \\mathrm{Sp} - 1)\\pi + 1 - \\mathrm{Sp}]^2} = \\frac{(\\mathrm{Se})(1 - \\mathrm{Sp})}{[(\\mathrm{Se})(\\pi) + (1 - \\mathrm{Sp})(1 - \\pi)]^2} = \\frac{(\\mathrm{Se})(1 - \\mathrm{Sp})}{[P(+)]^2}\n$$\nFor a diagnostic test to be informative, its sensitivity $\\mathrm{Se}$ must be greater than $0$ and its specificity $\\mathrm{Sp}$ must be less than $1$. Thus, $\\mathrm{Se}  0$ and $1 - \\mathrm{Sp}  0$. The product $(\\mathrm{Se})(1 - \\mathrm{Sp})$ is therefore positive. The denominator, $[P(+)]^2$, is the square of a probability and is also positive (as long as a positive test is possible). Since the derivative is strictly positive for $\\pi \\in (0,1)$, the function $\\mathrm{PPV}(\\pi)$ is a monotonically increasing function of the pretest probability $\\pi$.\n\n### Part 2: Numerical Calculation of PPV\n\nWe apply the derived expression to compute the numerical value of the PPV for the child described, using the given parameters: $\\mathrm{Se}=0.90$, $\\mathrm{Sp}=0.95$, and $\\pi=0.01$.\n\nFirst, we calculate the values for the components of the formula:\n- $\\mathrm{Se} = 0.90$\n- $\\pi = 0.01$\n- $1 - \\mathrm{Sp} = 1 - 0.95 = 0.05$\n- $1 - \\pi = 1 - 0.01 = 0.99$\n\nNow, substitute these into the $\\mathrm{PPV}$ formula:\n$$\n\\mathrm{PPV} = \\frac{(0.90)(0.01)}{(0.90)(0.01) + (0.05)(0.99)}\n$$\nCalculate the numerator and the terms in the denominator:\n- Numerator: $0.90 \\times 0.01 = 0.009$\n- Denominator, first term (true positives): $0.90 \\times 0.01 = 0.009$\n- Denominator, second term (false positives): $0.05 \\times 0.99 = 0.0495$\n- Denominator (total probability of a positive test): $0.009 + 0.0495 = 0.0585$\n\nSo, the PPV is:\n$$\n\\mathrm{PPV} = \\frac{0.009}{0.0585}\n$$\nPerforming the division:\n$$\n\\mathrm{PPV} \\approx 0.15384615...\n$$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $1$, $5$, $3$, and $8$. The fifth significant digit is $4$, which is less than $5$, so we do not round up the last digit.\n$$\n\\mathrm{PPV} \\approx 0.1538\n$$\nThis result demonstrates that even with a positive test from an assay with relatively high sensitivity and specificity, the low pretest probability results in a post-test probability of disease of only about $15.4\\%$.", "answer": "$$\n\\boxed{0.1538}\n$$", "id": "5167611"}]}